Search
for
Sort by
Research 331–360 of 1000+
- Effects of melatonin administration on mental health parameters, metabolic and genetic profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial
- Prevalence of hepatic steatosis in women with polycystic ovary syndrome
- Androgen receptor gene polymorphism and polycystic ovary syndrome
- Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome
- Diagnostic Criteria for Polycystic Ovarian Syndrome
- Animal Models and the Developmental Origins of Polycystic Ovary Syndrome: Increasing Evidence for the Role of Androgens in Programming Reproductive and Metabolic Dysfunction
- The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function
- Serum Levels of Retinol-Binding Protein 4 and Adiponectin in Women with Polycystic Ovary Syndrome: Associations with Visceral Fat But No Evidence for Fat Mass-Independent Effects on Pathogenesis in This Condition
- Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome.
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review
- Presence of polycystic ovary syndrome is associated with longer anogenital distance in adult Mediterranean women
- Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
- Mood disorders and quality of life in polycystic ovary syndrome
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Normalization of testosterone levels using a low estrogen-containing oral contraceptive in women with polycystic ovary syndrome.
- Reconsidering the Polycystic Ovary Syndrome (PCOS)
- Quercetin and polycystic ovary syndrome, current evidence and future directions: a systematic review
- Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats
- Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis
- Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- A guide to understanding polycystic ovary syndrome (PCOS)
- THERAPY OF ENDOCRINE DISEASE: Treatment of hirsutism in the polycystic ovary syndrome
- Polycystic ovary syndrome (PCOS)
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism
- Common variants in the sex hormone-binding globulin gene (SHBG) and polycystic ovary syndrome (PCOS) in Mediterranean women